Skip to main content

Table 1 Metabolic risk profiles and characteristics of analysis population at the most recent examination point

From: Media use trajectories and risk of metabolic syndrome in European children and adolescents: the IDEFICS/I.Family cohort

  Most recent examination point All
W2 W3  
Sex
Boys Girls Boys Girls
N (%) N (%) N (%) N (%) N (%)
All 2550 (24.6) 2543 (24.5) 2594 (25.0) 2672 (25.8) 10,359 (100.0)
DM trajectory
 Below mean 1274 (12.3) 1249 (12.1) 1312 (12.7) 1546 (14.9) 5381 (51.9)
 Above mean 1276 (12.3) 1294 (12.5) 1282 (12.4) 1126 (10.9) 4978 (48.1)
Age group
  < 12 years 2550 (24.6) 2543 (24.5) 1410 (13.6) 1428 (13.8) 7931 (76.6)
  ≥ 12 years 0 (0) 0 (0) 1184 (11.4) 1244 (12.0) 2428 (23.4)
ISCEDa
 Low 143 (1.4) 121 (1.2) 147 (1.4) 139 (1.3) 550 (5.3)
 Medium 1088 (10.5) 1089 (10.5) 1104 (10.7) 1160 (11.2) 4441 (42.9)
 High 1297 (12.5) 1309 (12.6) 1323 (12.8) 1353 (13.1) 5282 (51.0)
 Missing 22 (0.2) 24 (0.2) 20 (0.2) 20 (0.2) 86 (0.8)
HDAS
 High 1336 (12.9) 1395 (13.5) 1085 (10.5) 1114 (10.8) 4930 (47.6)
 Low 1097 (10.6) 1013 (9.8) 1426 (13.8) 1469 (14.2) 5005 (48.3)
 Missing 117 (1.1) 135 (1.3) 83 (0.8) 89 (0.9) 424 (4.1)
Snack intake
 High 1012 (9.8) 967 (9.3) 1643 (15.9) 1610 (15.5) 5232 (50.5)
 Low 1263 (12.2) 1261 (12.2) 723 (7.0) 858 (8.3) 4105 (39.6)
 Missing 275 (2.7) 315 (3.0) 228 (2.2) 204 (2.0) 1022 (9.9)
Puberty status
 Pre-pubertal 1123 (10.8) 999 (9.6) 1387 (13.4) 1514 (14.6) 5023 (48.5)
 Pubertal 0 (0.0) 0 (0.0) 1040 (10.0) 1035 (10.0) 2075 (20.0)
 Missing 1427 (13.8) 1544 (14.9) 167 (1.6) 123 (1.2) 3261 (31.5)
Country
 Italy 326 (3.1) 297 (2.9) 530 (5.1) 514 (5.0) 1667 (16.1)
 Estonia 269 (2.6) 301 (2.9) 403 (3.9) 444 (4.3) 1417 (13.7)
 Cyprus 327 (3.2) 333 (3.2) 524 (5.1) 509 (4.9) 1693 (16.3)
 Belgium 311 (3.0) 303 (2.9) 103 (1.0) 126 (1.2) 843 (8.1)
 Sweden 366 (3.5) 361 (3.5) 295 (2.8) 307 (3.0) 1329 (12.8)
 Germany 209 (2.0) 215 (2.1) 354 (3.4) 358 (3.5) 1136 (11.0)
 Hungary 359 (3.5) 380 (3.7) 205 (2.0) 220 (2.1) 1164 (11.2)
 Spain 383 (3.7) 353 (3.4) 180 (1.7) 194 (1.9) 1110 (10.7)
Abdominal adiposity
 No 1875 (18.1) 1831 (17.7) 1754 (16.9) 1867 (18.0) 7327 (70.7)
 Yes 664 (6.4) 708 (6.8) 821 (7.9) 781 (7.5) 2974 (28.7)
 Missing 11 (0.1) 4 19 (0.2) 24 (0.2) 58 (0.6)
Elevated BP
 No 1944 (18.8) 2037 (19.7) 2109 (20.4) 2209 (21.3) 8299 (80.1)
 Yes 548 (5.3) 443 (4.3) 419 (4.0) 390 (3.8) 1800 (17.4)
 Missing 58 (0.6) 63 (0.6) 66 (0.6) 73 (0.7) 260 (2.5)
Dyslipidaemia
 No 1425 (13.8) 1406 (13.6) 1542 (14.9) 1599 (15.4) 5972 (57.7)
 Yes 385 (3.7) 408 (3.9) 315 (3.0) 292 (2.8) 1400 (13.5)
 Missing 740 (7.1) 729 (7.0) 737 (7.1) 781 (7.5) 2987 (28.8)
Insulin resistance
 No 1599 (15.4) 1520 (14.7) 1480 (14.3) 1504 (14.5) 6103 (58.9)
 Yes 442 (4.3) 496 (4.8) 332 (3.2) 342 (3.3) 1612 (15.6)
 Missing 509 (4.9) 527 (5.1) 782 (7.5) 826 (8.0) 2644 (25.5)
MetS
 No 1607 (15.5) 1605 (15.5) 1627 (15.7) 1668 (16.1) 6507 (62.8)
 Yes 159 (1.5) 165 (1.6) 127 (1.2) 117 (1.1) 568 (5.5)
 Missing 784 (7.6) 773 (7.5) 840 (8.1) 887 (8.6) 3284 (31.7)
  1. a W2 second wave of follow-up, W3 third examination wave, DM digital media, ISCED parental educational status, HDAS healthy diet adherence score (diet quality), BP blood pressure, MetS metabolic syndrome